Jerini AG
www.jerini.com
Already a Biomedtracker subscriber?
You have access to the full company record through your subscription
Want to become a subscriber?
Subscribers get more company details, updates, company financials and company products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Jerini AG
IPO Outlook: 2021 Saw Record Numbers But Poor Returns; 2022 Looks Muted
Bookmark
-
Analysis
Initial public offering momentum decelerated as stock prices declined last year, but even with lower valuations making M&A more attractive, the IPO market this year is expected to be active.
Company Information
- Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Advertisement
Advertisement
Jerini AG
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice